PLG and neoplasm: Blocking csGRP78 with an anti-GRP78 antibody was shown to protect against the cell invasion of LoVo, a human colon adenocarcinoma cell line, indicating that csGRP78 may bind to plasminogen to promote tumor cell migration and invasion [42].